MARCO CARPIO: Open Payments
NPI 1184633158 · LYNBROOK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 13 payments from 7 companies in 2025. Trend: 2023 $24 · 2024 $51 · 2025 $319
Food & beverage: $304Education: $15
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $96 |
| Teva Pharmaceuticals USA, Inc. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Luye Pharma (USA) Ltd. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: ARISTADA, UZEDY, FANAPT, REXULTI, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, Auvelity, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
